Biotech
This Week’s Catalyst Calendar Summary – 12/30/11
31 December 2011 – 12:16 am PST
Comments Off
$CBRX FDA Approval Key to Achieving Sustained Profitability
29 December 2011 – 12:16 am PST
Comments Off
Written by Mike Havrilla-Columbia Labs (NASDAQ:CBRX) is focused on the development of sustained-release products that are based on its bio-adhesive drug delivery technology platform.
Continue reading...$NEPT Seeking to Develop a Better Omega-3 Prescription Drug
21 December 2011 – 12:16 am PST
Comments Off
Written by Mike Havrilla–Neptune (NASDAQ:NEPT) is focused on the development and marketing of over-the-counter (OTC) / nutraceutical products based on its patented Neptune Krill Oil (NKO). In addition the Company’s subsidiary is developing a prescription-grade version of NKO that is summarized below.
Continue reading...$DSCO Seeking FDA Approval for Premature Infant Lung Drug
20 December 2011 – 12:16 am PST
Comments Off
Discovery Labs (NASDAQ:DSCO) specializes in the development of new treatments for respiratory disease. Below is a summary of the Company’s late-stage pipeline.
Continue reading...
3 January 2012 – 12:16 am PST
Comments Off